|
|
Please type responses here: |
|
First Name:
|
|
|
Last Name:
|
|
|
Email Address:
|
|
|
Retype Email Address:
|
|
|
Title:
|
|
|
Institution:
|
|
|
Phone Number:
|
|
|
City:
|
|
|
State/Province:
|
|
|
Postal/Zip Code:
|
|
|
Country:
|
|
|
Overall, how would you rate your satisfaction with this webinar?
|
Extremely satisfied
Very satisfied
Somewhat satisfied
Dissatisfied
|
|
Your feedback helps your webinar producer and sponsor improve the overall quality of their products and services.
|
|
What is your role in the purchasing process? Please choose all that apply:
|
I am the purchasing decision maker
I influence the purchasing decisions
I gather information on product and services
I have no part in purchasing decision
|
|
What is the biggest challenge in your facility?
|
|
|
Please fill in the specialty or specialties your facility services:
|
|
|
Who do you currently purchase the majority of your products from? Please choose all that apply:
|
Fisher Healthcare
Another Distribution Channel
Direct from Manufacturer
|
|
How do you like to receive follow up product information? Please choose all that apply:
|
Clinical Expert - Fisher Healthcare Representative
Webinar
Email
Phone call
Mailed pamphlet
|
|
What sources do you rely on to get industry news? Please choose all that apply:
|
Email
Webinar
Trade meetings/Clinical conferences
Print/Web Publications
Website
Lab Manager
Emails
CLSI updates
Colleagues and social media
Not known
|
|
If you chose 'website' in the question above, please specify the website(s):
|
|
|
Do you have a current GPO affiliation?
|
Yes, primarily Health Trust
Yes, primarily Intalere (formerly Amerinet)
Yes, primarily Premier
Yes, primarily Vizient (formerly Novation & MedAssets)
Yes, but the GPO is not listed (please add your GPO in the space provided)
Mulitple GPOs (please add your affiliated GPO in the space provided)
No, not affiliated
|
|
If your GPO wasn’t mentioned above, please list it here:
|
|
|
Would you like more information on this webinar topic?
|
Yes
No
|
|
How can QuidelOrtho help your lab in preparing for the CLIA 2024 Proficiency Testing changes?
|
|
|
Would you like to hear how QuidelOrtho can help streamline/automate your laboratory?
|
Yes, please
No, thank you
|
|
Which QuidelOrtho laboratory solution(s) would you like to hear more about?
|
Clinical Chemistry and Immunoassay solutions
Immunohematology solutions
Molecular diagnostic solutions
Point-of-care Immunoassay solutions
|
|
Would you like to receive EITHER ASCLS PACE credit, program number 354-014-24 (California Agency #0001), OR Florida CE credit OR a certificate of attendance for the session, "Preparing Your Laboratory for the CLIA 2024 Proficiency Testing Changes"? (If no, you do not need to complete the following questions.)
|
Yes
No
|
|
Which continuing education credit would you like to receive for this session?
|
PACE
Florida CE Credit
Certificate of Attendance
No, I would not like to receive continuing education credit for this session
|
|
If you are planning to submit this session for Florida CE Credit, please provide your Florida license number:
|
|
|
If the following is true, please answer "Yes": I have attended the full instructional time for this program. I understand that completion of the program is necessary to receive the contact hours awarded for the program.
|
Yes
No
|
|
SPEAKER RATING
|
|
To what extent was the speaker knowledgeable, organized and effective during the presentation? (Rate on a scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
To what extent did the speaker clarify and focus on the stated objectives? (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
To what extent were the speaker's teaching methods & aids appropriate & effective? (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
OBJECTIVES RATING:
To what extent was each objective achieved?
|
|
Summarize the historical aspects and other provisions of the CLIA Proficiency Testing Final Rule. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
Describe the finalized CLIA requirements pertaining to clinical chemistry and immunoassays, including acceptable limits and total allowable error. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
Discuss applicable steps laboratorians can take to adhere to CLIA regulatory changes. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
Apply essential best practices to avoid noncompliance in proficiency testing and CLIA inspections. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
PROGRAM CONTENT RATING
|
|
To what extent did the program content relate to the program's objectives? (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
Rate the contribution of this session to your overall knowledge of this subject. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
Rate your overall degree of satisfaction with this session. (Rate on scale from 1 - 5 with 1 being the lowest and 5 being the highest)
|
1
2
3
4
5
|
|
Comments:
|
|
|
Thank you for attending this webinar and completing this evaluation. Questions? Call Whitehat Communications at 434 202 8365.
|
|
|
